Therapixel: Using AI to improve breast cancer detection
- France
- 6 min read
- Apr 19, 2021
- By Sophie Douez
AI-powered MammoScreen © Therapixel
Therapixel is raising €15m for commercial expansion of its AI-powered MammoScreen that gives accurate breast cancer screening results within minutes
French medtech Therapixel is gearing up to boost the clinical adoption of its award-winning MammoScreen across Europe and the US. The AI-powered breast cancer detection software enables radiologists to read digital mammograms within minutes, detecting suspicious lesions or cancerous tissues with greater accuracy than conventional screening systems.
Hundreds of thousands of mammogram images were used to train the MammoScreen algorithm to recognize cancer lesions in thousands of cases. The patented MammoScreen Score provides an at-a-glance suspicion indicator of cancer from one to 10. Ma...
Hundreds of thousands of mammogram images were used to train the MammoScreen algorithm to recognize cancer lesions in thousands of cases. The patented MammoScreen Score provides an at-a-glance suspicion indicator of cancer from one to 10. Ma...
The rest of the content is only available if you are logged in.
IN THIS INSIGHT
MOST VIEWED
RECOMMENDED